What Causes Branch Retinal Vein Occlusion?

One of the smaller retinal veins becomes blocked, interrupting blood drainage from the light-sensitive tissue at the back of the eye. The clot typically forms at an arteriovenous crossing, where a retinal artery lies directly over a retinal vein, and where atherosclerotic thickening of the arterial wall compresses the vein until blood flow slows and thromboses. That single mechanical pinch, combined with systemic conditions such as hypertension, diabetes mellitus, and hyperlipidemia, accounts for most cases.

This walkthrough breaks down the mechanics of how a retinal vein gets pinched shut, the systemic conditions that quietly set the stage, and the eye-specific factors that turn risk into a clot.

The Anatomy of a Blocked Retinal Vein

The retina is a thin layer of tissue lining the back of your eye, and it depends on a constant, unimpeded flow of blood. Retinal arteries deliver oxygen-rich blood into the tissue, and retinal veins carry oxygen-poor blood back out toward the optic nerve and the larger vessels of the body. When a vein is blocked, blood and fluid leak into the surrounding retinal tissue, producing the sudden blurring or visual distortion you may notice.

How arteries and veins share space at crossing sites

Retinal arteries and veins run in parallel through the nerve fiber layer, sharing a common connective tissue sheath wherever they cross. That shared sheath is the anatomical setting for the most common mechanism behind this condition. At each crossing, a single artery sits directly on top of a single vein, separated only by a thin wall and the shared sheath.

In a healthy eye, this crossing is no problem at all. Blood moves freely in both directions, the vessel walls stay thin and flexible, and the surrounding retinal tissue remains clear. Trouble starts when one of the two vessels becomes stiff or thickened and begins to press on the other.

Why a thickened artery pinches the vein

High blood pressure, diabetes, and high cholesterol damage the inner lining of arteries and encourage the buildup of fatty plaque in the arterial wall. Atherosclerosis, the slow hardening and narrowing of arteries that follows, makes the normally soft arterial wall rigid and bumpy. Where that hardened artery crosses a vein, the vein gets compressed, sometimes severely enough to narrow its channel to a slit.

Once the vein is pinched, blood leaving the retina must squeeze through a much smaller opening. Flow slows, pressure builds upstream of the crossing, and the small vessels behind the blockage begin to leak. This is the starting point of the cascade that turns a slow trickle into a full occlusion.

From slowed flow to a complete clot

Sluggish blood is far more likely to clot than blood moving at normal speed. Platelets and clotting proteins, which usually flow past one another without sticking, begin to clump in the low-pressure zone behind the compression. Within hours to days, a thrombus can form inside the vein at the crossing point, completing the occlusion.

Because only the branch downstream of the clot loses drainage, the damage stays localized to that quadrant of the retina. The rest of the retinal circulation continues to function, which is why the condition affects only a portion of your visual field rather than the whole eye.

Systemic Conditions That Set the Stage for BRVO

Local anatomy explains where the clot forms, but systemic conditions explain why it forms in the first place. Several chronic medical conditions quietly remodel the retinal vessels over years, and most people who experience a branch retinal vein occlusion carry at least one of them, often undiagnosed until the eye event forces a broader workup.

Hypertension as the leading modifiable risk

High blood pressure is the single most consistent risk factor across population studies of this condition. Chronically elevated pressure damages the delicate endothelial lining of retinal arteries and encourages wall thickening that turns a flexible crossing into a rigid pinch point. That pattern aligns with guidance from the National Eye Institute, which notes that vascular diseases of this kind disproportionately affect people with poorly controlled blood pressure.

Estimates from large cohort data suggest that more than half of patients who present with a new branch retinal vein occlusion carry a diagnosis of hypertension, and many more have elevated readings they did not know about. Controlling blood pressure does not undo an existing clot, but it sharply lowers the chance of a second event in either eye.

Diabetes mellitus and vessel wall damage

Diabetes injures the lining of both arteries and veins throughout the body, and the retina is one of the earliest and most visible places this shows up. Chronically high blood glucose encourages the formation of advanced glycation end products, sticky molecules that stiffen vessel walls and make them more prone to leakage. People with diabetes also tend to have higher blood viscosity, which slows flow through any narrowed crossing.

The damage from diabetes compounds the damage from high blood pressure, so the two together raise risk far more than either alone. A dilated eye exam, often part of routine diabetes care, sometimes picks up subtle retinal changes years before a full occlusion occurs.

Hyperlipidemia and atherosclerotic plaque

Cholesterol and triglyceride levels climbing above target ranges feed fatty deposits that thicken arterial walls at critical junctions. A vessel that was once smooth and elastic becomes lumpy and rigid, and at every crossing it now presses harder on the underlying vein. That is one of the reasons the American Academy of Ophthalmology lists lipid control as part of the standard workup after a new branch retinal vein occlusion diagnosis.

Lowering LDL cholesterol and triglycerides through diet, exercise, and clinician-supervised management helps slow further plaque buildup. It does not reverse the clot already in place, but it changes the long-term trajectory of your vascular health.

Hypercoagulable states and inherited clotting tendencies

A small but important subset of patients develop branch retinal vein occlusion because their blood itself clots more easily than it should. Conditions such as antiphospholipid syndrome, factor V Leiden mutation, and elevated homocysteine all shift the balance toward clot formation. In people under 50 with no obvious vascular risk factors, a thrombophilia workup is often the next step.

These conditions are uncommon compared with hypertension or diabetes, but they are worth identifying because the management strategy differs. A young patient with recurrent occlusions in either eye often needs hematology input alongside ophthalmology.

Local Eye Factors and Mechanical Triggers

Systemic conditions do most of the heavy lifting, but local anatomy inside your eye can tip the balance. Certain structural features of the optic nerve, the eyeball, and the retinal vessels themselves create an environment where a clot is more likely to form.

Glaucoma and elevated intraocular pressure

Glaucoma raises the pressure inside your eye and changes how blood flows through the retinal vessels. Higher intraocular pressure compresses veins as they exit the eye through the optic nerve head, which raises venous pressure throughout the retinal circulation. That extra backpressure makes each arteriovenous crossing more vulnerable to occlusion.

Patients with open-angle glaucoma show a measurably higher incidence of branch retinal vein occlusion than the general population. Treating and monitoring the glaucoma protects both the optic nerve and the retinal circulation.

Short axial length and crowded disc configurations

Axial length is the front-to-back distance of your eye, and shorter eyes pack a lot of structure into a small space. A short eye often has a crowded optic disc, where vessels enter and exit through a tight opening. Crowding raises resistance to venous outflow and makes the small branches of the central retinal vein more susceptible to compression further out in the retina.

That is one reason some patients with otherwise healthy vasculature still develop a branch occlusion. The anatomy of the eye itself contributed, even when blood pressure and cholesterol look fine.

Optic disc drusen and structural abnormalities

Small calcified deposits accumulate at the optic nerve head, sometimes visible as yellowish bodies on careful fundoscopic examination. They take up space in an already crowded area and can compress vessels as they leave the eye. The mechanical effect is similar to that of a short axial length: more resistance, less margin for error when systemic risk factors are present.

Other structural abnormalities, including congenital vessel tortuosity and atypical branching patterns, can also predispose specific eyes to occlusion. None of these alone usually causes a clot, but they make the system easier to push past its tipping point.

Inflammatory conditions affecting vessel walls

Vasculitis, sarcoidosis, and other inflammatory disorders can directly attack the walls of retinal veins. When the wall is inflamed, it swells, becomes sticky, and attracts platelets. A branch retinal vein occlusion in a young adult, or one that occurs in both eyes, sometimes points to an underlying inflammatory process rather than to atherosclerosis.

Distinguishing inflammatory occlusions from atherosclerotic ones matters because the management strategy changes. Steroid-sparing immunosuppressive regimens under specialist supervision are sometimes needed in addition to standard ophthalmologic care.

Once systemic drivers have been weighed, the local anatomy of the eye itself can independently tip the balance toward occlusion.

Lifestyle, Demographics, and Non-Modifiable Risks

Some risk factors are within your control to change. Others are not, and they still shape the probability of an event. Understanding which is which helps you focus on the levers that actually move your risk.

Age as the strongest non-modifiable predictor

The risk of branch retinal vein occlusion climbs sharply with age. Most cases occur after age 60, when cumulative vascular damage, more frequent hypertension, and reduced vessel elasticity all converge. The condition is uncommon in patients under 40, and when it does appear in that group, a thorough workup for inherited or inflammatory causes is usually warranted.

Age itself is not something you can change, but the conditions that come with age, including high blood pressure and diabetes, are. Acting on those early keeps the risk profile closer to that of a younger person than to that of an untreated 70-year-old.

Cumulative vascular damage from smoking and sedentary habits

Smoking damages the endothelial lining of every vessel in the body, including the retinal arteries that cross over your veins. Sedentary habits and a diet high in processed foods compound the problem by raising blood pressure, blood glucose, and LDL cholesterol at the same time. Together, these habits accelerate the atherosclerotic process that creates the rigid arterial walls responsible for compressing retinal veins.

Quitting smoking and adding regular physical activity are two of the most powerful levers you have over the long-term trajectory of your retinal vascular health. They will not undo an existing clot, but they reduce the chance of a second event.

Hormone-related clotting changes

Estrogen-containing medications, including oral contraceptives and some hormone replacement regimens, raise the level of clotting proteins in circulation. In women who already carry other risk factors, this can be enough to push blood past the clotting threshold, particularly at a vulnerable crossing site. Pregnancy also raises clotting tendency and adds to the mechanical load on pelvic and retinal vessels.

Anyone with multiple vascular risk factors who is considering or currently using estrogen-containing therapy should review the decision with a clinician who understands both the systemic and ocular implications.

Family history and inherited disorders

Having parents or siblings who suffered early cardiovascular disease, stroke, or venous thromboembolism substantially increases your odds of carrying the same inherited risk variants. Factor V Leiden, prothrombin gene mutation, and protein C or S deficiencies are all heritable conditions that shift the clotting balance toward thrombosis. They are not common causes of branch retinal vein occlusion on their own, but they compound other risk factors.

Telling your ophthalmologist about any family history of clotting disorders or unusual venous events is a small step that can meaningfully change the workup.

The Biological Pathway From Risk to Blockage

The list of risk factors can feel disconnected until you see how they all funnel through one underlying framework. Virchow’s triad, a 19th-century model that still holds up, organizes the conditions needed for any clot to form: stasis, endothelial injury, and hypercoagulability. Branch retinal vein occlusion is essentially a textbook example of how all three converge at a single crossing site.

Stasis at a compressed crossing

Stasis means sluggish flow, and it is exactly what happens when a hardened artery presses on a vein. Blood that should be moving briskly back toward the optic nerve now creeps forward in eddies. The slower the flow, the more time platelets and clotting factors have to find each other and stick. In the retinal circulation, where vessels are tiny and crossings are tight, even modest compression is enough to produce stasis.

Endothelial injury from turbulence and inflammation

The inner lining of every blood vessel, the endothelium, normally keeps blood flowing smoothly and discourages clotting. Turbulent flow across a rough atherosclerotic surface scrapes that lining, exposing the tissue underneath to platelets. Chronic inflammation, whether from diabetes, smoking, or a vasculitis, leaves the endothelium chemically activated and sticky.

At a diseased crossing, both mechanical and chemical endothelial injury are happening at once. The vein wall, compressed from the outside, is also being irritated from within.

Hypercoagulability tipping the balance

Hypercoagulability is the third leg of the triad. Anything that raises the tendency of blood to clot, including inherited thrombophilias, estrogen therapy, smoking, and chronic inflammation, tips the local environment from stasis into actual thrombosis. Once the clot forms, the cascade is complete: outflow stops, upstream pressure rises, fluid leaks, and the retina swells in the area drained by that branch.

Why ischemia and macular edema follow

When a retinal vein stays blocked, the tissue it drains loses its outflow. Blood arrives through the artery but cannot leave, so capillaries become engorged and leaky. Fluid seeps into the macula, the small central part of the retina responsible for sharp vision, producing macular edema, the leading cause of vision loss after this event.

In some eyes, the blockage also reduces inflow enough that the affected retina becomes ischemic, meaning it does not get enough oxygen. Ischemic tissue releases vascular endothelial growth factor, a signal that triggers fragile new vessel growth. Both macular edema and neovascularization are the downstream consequences your ophthalmologist monitors most closely in the weeks and months after the initial event.

Tracing that mechanism forward makes it clear where early intervention and risk reduction actually pay off.

Reducing Your Risk and Recognizing Early Warning Signs

Most of the underlying causes of branch retinal vein occlusion are modifiable, and most of the worst outcomes come from delays in evaluation. A practical plan combines vascular risk reduction with prompt attention to new visual symptoms.

Control blood pressure, glucose, and cholesterol

Three numbers deserve the most attention in any prevention plan: blood pressure, blood glucose, and LDL cholesterol. Keeping each within the range your primary care clinician recommends directly reduces the rate of new atherosclerotic damage at retinal crossings. Home monitoring, regular labs, and adherence to clinician-supervised lifestyle or pharmacologic management all help.

Get regular dilated eye exams

A dilated fundus exam lets your ophthalmologist see the retinal arteries, veins, and crossings in detail. People with hypertension, diabetes, or a family history of vascular disease benefit from annual exams. Cotton-wool spots, scattered hemorrhages, and vessel changes at crossings can show up long before a full occlusion, and spotting them early gives you time to act.

“Sudden blurred or distorted vision in one eye is a reason for same-day ophthalmologic evaluation, not a wait-and-see situation. The window for the best outcomes is measured in days, not weeks.

Know what to expect at the ophthalmology workup

The workup typically includes visual acuity testing, a dilated exam, optical coherence tomography to image the macula, and fluorescein angiography to map retinal blood flow. Your ophthalmologist will also coordinate with your primary care physician to check blood pressure, blood glucose, and a lipid panel. Causation guides the follow-up plan: an inflammatory cause points toward rheumatology, a thrombophilia toward hematology, and atherosclerotic risk factors toward aggressive vascular risk reduction.

The single most important habit is taking vascular risk factors seriously before they become an eye event. Once a branch retinal vein occlusion occurs, controlling the underlying causes does more than protect the other eye. It protects your heart, your brain, and every other vascular bed in your body.

FAQ